European Commission Calls
Global Challenges and European Industrial Competitiveness
HEALTH
Call Identifier: HORIZON-HLTH-2024-DISEASE-09-01
European Partnership: One Health Anti-Microbial Resistance
The partnership should contribute to the priorities set in the European One Health Action plan to fight AMR and in the Council Recommendation on stepping up EU actions to combat antimicrobial resistance in a One Health (OH) approach that provide European frameworks with actions and objectives focused on areas with the highest added value for Member States, including boosting research development and innovation.
It should be structured along the following 3 main objectives:
1. Collaboration and alignment of Research and Innovation agendas on OH AMR
The Partnership should mobilise and link key AMR stakeholders, encompassing the human, veterinary, agricultural and environmental disciplines and including a broad spectrum of pathogens, bacteria, fungi, parasites and viruses, through a cross-cutting, interdisciplinary one health approach.
2. Boost Research and Innovation
The OH AMR Partnership should strengthen the European Research Area by supporting excellence in innovative research, capacity building, programmes for development of talent, widening the engagement of countries and sectors not yet involved.
3. Enhance knowledge translation and uptake
Facilitate translation of scientific knowledge into innovative solutions;
Connect, merge and align dissemination of outputs with other initiatives to support evidence-based policy in whole One Health domain;
Societal engagement by bridging science to society creating awareness of AMR challenges, value creation, support the wellbeing of citizens and sustainability of the environment.
Budget: 100.000.000 EUR, indicative number of grants: 1
Deadline: 25 September 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
The partnership should contribute to the priorities set in the European One Health Action plan to fight AMR and in the Council Recommendation on stepping up EU actions to combat antimicrobial resistance in a One Health (OH) approach that provide European frameworks with actions and objectives focused on areas with the highest added value for Member States, including boosting research development and innovation.
It should be structured along the following 3 main objectives:
1. Collaboration and alignment of Research and Innovation agendas on OH AMR
The Partnership should mobilise and link key AMR stakeholders, encompassing the human, veterinary, agricultural and environmental disciplines and including a broad spectrum of pathogens, bacteria, fungi, parasites and viruses, through a cross-cutting, interdisciplinary one health approach.
2. Boost Research and Innovation
The OH AMR Partnership should strengthen the European Research Area by supporting excellence in innovative research, capacity building, programmes for development of talent, widening the engagement of countries and sectors not yet involved.
3. Enhance knowledge translation and uptake
Facilitate translation of scientific knowledge into innovative solutions;
Connect, merge and align dissemination of outputs with other initiatives to support evidence-based policy in whole One Health domain;
Societal engagement by bridging science to society creating awareness of AMR challenges, value creation, support the wellbeing of citizens and sustainability of the environment.
Budget: 100.000.000 EUR, indicative number of grants: 1
Deadline: 25 September 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
HEALTH Call Identifier: HORIZON-HLTH-2024-DISEASE-12-01 European partnership for pandemic preparedness
The COVID-19 pandemic uncovered the challenges that European health care systems face in detecting, preventing, combatting and managing outbreaks of infectious diseases in a coordinated manner.
The scope of the partnership should encompass:
•basic research to accelerate the acquisition of knowledge on the biology of pathogens with epidemic or pandemic potential, their transmission and interaction with humans, animals and plants, in particular in view of emerging threats to human health.
•preclinical research aimed at better understanding of human diseases caused by pathogens with epidemic or pandemic potential and testing of related medical countermeasures.
•clinical research to support the generation of novel solutions, in particular the development (phase I to phase III) of medical countermeasures, e.g. vaccines, diagnostics, therapeutics and digital solutions, to prevent or mitigate outbreaks from pathogens with epidemic or pandemic potential.
•a key feature should be the consolidation and further development of an ever-warm network of clinical trial sites applying the same quality standards and ensuring a baseline of continuous clinical trial activity across a wide and diverse range of clinical trial site.
•the development, testing and validation of new methods and tools, including those based on artificial intelligence and computer modelling, to improve surveillance and diagnosis and control of the spread of pathogens with epidemic or pandemic potential.
Budget: 50.000.000 EUR, indicative number of grants: 1
Deadline: 26 November 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
HEALTH Call Identifier: HORIZON-HLTH-2024-DISEASE-13-01 Implementation research for management of multiple long-term conditions in the context of non-communicable diseases (Global Alliance for Chronic Diseases - GACD)
The European Commission is a member of the Global Alliance for Chronic Diseases (GACD), an alliance of international funding agencies representing over 80% of the world’s public health research funding and the first collaboration of its kind to specifically address non-communicable diseases (NCDs).
Proposals should address all of the following activities:
•Provide a research plan using validated implementation research frameworks or hybrid design research.
•Have an appropriate strategy for measuring implementation research outcomes and real-world effectiveness outcomes and indicators.
•Specifically address health equity and the principles of Universal Health Coverage.
•Engage an appropriately expert and skilled research team which can ensure a suitable multidisciplinary approach and that demonstrates equitable partnership and shared leadership between high-income countries (HICs)- low- and middle-income countries (LMICs), and/or non-Indigenous–Indigenous members of the project team and external stakeholders through a clear governance strategy.
•Provide a stakeholder engagement strategy with evidence of support/engagement from key stakeholders for delivering patient-centred care and a pathway to sustain the proposed intervention after the funding ends.
•Provide opportunities for implementation research capacity building for early career researchers and team members from lower resourced environments, such as LMICs or disadvantaged communities.
•Ensure meaningful involvement of early career team members, including at least one early career member as a co-investigator.
Budget: 3.000.000 to 4.000.000 EUR, indicative number of grants: 5
Deadline: 26 November 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
HEALTH Call Identifier: HORIZON-HLTH-2024-CARE-14-01 Pre-commercial procurement for environmentally sustainable, climate neutral and circular health and care systems
The healthcare sector is responsible for 4-5% of global total carbon emissions contributing significantly to Europe's carbon footprint and to the generation of large amounts of plastics and other waste, including chemical waste through the discharge of pharmaceuticals and diagnostic chemicals as well as disinfectants and antimicrobial resistant pathogens into the wastewater system.
Proposals should target either:
•Direct and indirect footprint deriving from the provision and/or delivery of care (excluding infrastructural elements related to building, transport logistics and food footprints).
•Circularity, waste production and treatment.
•Footprint from the chain of suppliers in making and delivering products, or services.
•More efficient use of resources, decreasing the overall sector footprint while addressing the constantly increasing demand for healthcare.
Budget: 3.000.000 to 5.000.000 EUR, indicative number of grants: 3
Deadline: 26 November 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Mission: Cancer
Call Identifier: HORIZON-MISS-2024-CANCER-01-01
Use cases for the UNCAN.eu research data platform
The successful proposal should:
•Develop the UNCAN.eu platform by integrating and, where relevant, complementing existing or planned data nodes of European research infrastructures and/or other national infrastructures that may link various cancer data holders across Member States and Associated Countries.
•Provide tools, services and workflows to researchers across data nodes for dataset creation, standardisation, data discovery, secure access, management, visualization, harmonization, analysis and other functions as appropriate.
•Design and implement a rich and diverse portfolio of use-cases to inform, steer the development and demonstrate the validity of the UNCAN.eu platform. At least one use-case should target a cancer type with a 5-year overall survival of less than 50% from the time of diagnosis. A second use-case should target paediatric cancer.
•At the same time, use-cases should be functional to the design and implementation of UNCAN.eu to increase the diversity of digital tools and services available for cancer researchers.
•The successful consortium should develop innovative approaches, to integrate and analyse heterogeneous data from multiple sources and different research domains, including the participation of the necessary interdisciplinary set of European infrastructures and national data nodes.
• Give emphasis to data being managed and shared in line with the FAIR principles, and the concept of FAIR-by-design is applied wherever possible.
Budget: 30.000.000 EUR, indicative number of grants: 1
Deadline: 18 September 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Mission: Cancer Call Identifier: HORIZON-MISS-2024-CANCER-01-02 Support dialogue towards the development of national cancer data nodes
The proposal should address all of the following:
•Foster the development of national cancer data nodes through policy dialogues at national level with relevant actors in the research and innovation community, digital health and public health policy.
•Identify and build synergies between European infrastructures related to health data access and health data sharing for primary and secondary data uses (e.g. MyData@eu, HealthData@eu, ELIXIR, BBMRI, and others), and other initiatives relevant for the UNCAN.eu and ECPDC platforms.
•Identify challenges and barriers to the effective future implementation of the UNCAN.eu and the ECPDC platforms at national and European levels and propose operational solutions to overcome them.
•Identify population subgroups with poor digital skills and geographical areas with limited digital resources that might prevent the use of those platforms and propose solutions to reduce the digital divide.
Budget: 2.999.999 EUR, indicative number of grants: 1
Deadline: 18 September 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Mission: Cancer Call Identifier: HORIZON-MISS-2024-CANCER-01-03 Accessible and affordable tests to advance early detection of heritable cancers in European regions
There is a need to validate, pilot, and upscale easy-to-use genetic, multi-omics or other biomarker-based tests for early detection of cancers with an underlying heritable genetic risk, for uptake in regional or national healthcare systems.
Proposals should address all of the following:
•Validate easy-to-use, affordable and accessible genetic, multi-omics or other biomarker-based cancer tests for early detection of cancers with an underlying heritable genetic risk for uptake in regional or national healthcare systems.
•Stratify the to-be-tested population by sex, gender, age or other determinants.
•Be compliant with GDPR and take into account socio-economic status, limited health literacy, limited awareness of disease symptoms and access for people in remote and rural areas.
•Tests can be based on, for example, polygenic cancer risk scores, algorithms, machine learning, biomarkers, cell lines, organoids, liquid biopsies, medical devices, or wearables and other digital applications.
•Co-create with end-users, including (citizens, and health professionals, such as psychologists) living in the targeted regions, aspects such as the innovation life cycle, priority definition, design, development, testing and piloting stages as well as risk assessment, counselling, health education, and acceptability.
•Extensively pilot and upscale genetic, multi-omics or other biomarker-based testing for use in early detection programmes in at least three regions across at least three different Member States or Associated Countries.
Budget: 10.000.000 to 12.000.000 EUR, indicative number of grants: 3
Deadline: 18 September 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Mission: Cancer Call Identifier: HORIZON-MISS-2024-CANCER-01-04 Support a pragmatic clinical trial programme by cancer charities
The EU contribution aims to facilitate the coordination and networking between charities themselves as well as with relevant stakeholders across Member States and Associated Countries. The EU contribution will not co-fund the trials.
Proposals should address all of the following:
•Together, registered cancer charities and foundations across Europe, organise, fund and implement at least two transnational calls for proposals, resulting in grants to academic investigator-led third parties to conduct randomised multi-centre pragmatic clinical trials.
•Organise annual networking activities between charities, the successful academic investigators, citizen representatives and stakeholders across Member States and Associated Countries across Europe.
•With respect to the pragmatic trials.
•The chosen intervention(s) should be adapted to the particular needs of the target population and to the specificities of the provision of care at local, regional, or national level, duly reflecting the diversity across Member States and Associated Countries.
•The chosen intervention(s) should take into account socio-economic and biological stratification.
•The successful grants to third parties will address interventions for patients with cancers with a 5-year overall survival of less than 50% from time of diagnosis or rare cancers, at any stage of the disease, for any cancer subtype, in any age group or part of society.
•Timely contact with regulatory authorities should be foreseen to inform the trial design and feasibility.
Budget: 2.999.999 EUR, indicative number of grants: 1
Deadline: 18 September 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Mission: Cancer Call Identifier: HORIZON-MISS-2024-CANCER-01-05 Improving the understanding and management of late-effects in adolescents and young adults (AYA) with cancer
This topic will contribute to the achievement of the Mission’s objective to improve the quality of life of cancer patients, survivors and their families. The focus should be exclusively on adolescent and young adult (AYA, age range 15-39) cancer patients and survivors.
Proposals should focus on one or more cancer types and address only one of the following interventions:
•Building on data from existing or newly established AYA patient cohorts, ensuring comparability of data across participating countries as appropriate, obtain a thorough assessment by cancer type of the prevalence, specific effect(s), severity, time of onset, relative risk, and risk factors associated to late effects in AYA cancer patients.
•Develop, test and scale-up evidence-based screening methods for the early detection of late-effects in AYA cancer patients.
•Develop, test and scale up in real-life settings, innovative, holistic approaches and tools (including digital tools), optimising cancer treatment and follow-up regimens to prevent, reduce and/or effectively manage late-effects, including psycho-social aspects. Approaches could focus on education, sports, nutrition, medical follow-up and counselling.
Budget: 4.000.000 to 6.000.000 EUR, indicative number of grants: 6
Deadline: 18 September 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Mission: Cancer Call Identifier: HORIZON-MISS-2024-CANCER-01-06 An information portal for the European Cancer Patient Digital Centre
Proposals should address all the following:
•Design, develop and deploy, a pilot European Cancer Patient Digital Centre (ECPDC) information portal to complement the existing Knowledge Centre on Cancer (KCC). The knowledge base of the information portal will cover the cancer patient journey from diagnosis to life after cancer.
•The information to include in the knowledge base, complements information provided through the KCC, adding to it and expanding its contents.
•The selection of the information provided to the users should be based on explicit and robust criteria and be transparent.
•Provide a validated workflow for reviewing, selecting and timely updating the knowledge base when new clinical information and scientific evidence arise.
•An AI-based virtual assistant is implemented in the portal to interact with users and improve their experience by delivering information tailored to user cultural background, individual (clinical) circumstances, needs, preferences and/or expectations.
•All the developed IT-solutions and workflows should be open source and made available.
•The pilot ECPDC information portal should also include other information that may be relevant to cancer patients and survivors and their families such as options to cross-border health care, participation to clinical research, psychosocial and legal support options, guidance and support for returning to study or to work, financial issues and survivors’ rights.
•To ensure an efficient and useful digital platform for patients, the pilot ECPDC information portal should be tested and validated by an appropriate number of cancer patients and survivors of different cancer types and age groups.
Budget: 11.999.999 EUR, indicative number of grants: 1
Deadline: 18 September 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Mission: Soil Call Identifier: HORIZON-MISS-2024-SOIL-01-05 Soil health, pollinators and key ecosystem functions
Proposed activities should:
•Improve the knowledge on the biology, ecology and population dynamics of insects spending part of their life cycle on or in the soil, with specific focus on ground-nesting pollinators, as well as on the interactions between life below and above ground. Focus should be put on lesser-known species, regions and major threats and causes of their decline.
•Contribute to the development of monitoring methods including on threats and pressures that can be of relevance for the pollinator monitoring framework, under the revised EU Pollinators Initiative : “A New deal for Pollinators”.
•Identify soil conditions associated with a high diversity of pollinators and map regions of particular importance for the protection of soil-dependent pollinators.
•Analyse the effects of different soil management practices, including different plant protection and/or soil management methods, across different farming systems, such as organic farming or conventional approaches, and compare intensively managed areas with protected areas.
•Develop and demonstrate soil remediation and mitigation practices to address the causes of insect (and in particular pollinator) decline.
•Provide recommendations for best soil management practices to integrate pollinator conservation and restoration across the wider landscape and enhance habitat connectivity and pollination services.
Budget: 7.500.000 EUR, indicative numer of grants: 1
Deadline: 08 October 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Mission: Soil Call Identifier: HORIZON-MISS-2024-SOIL-01-06 Harnessing the multifunctional potential of soil biodiversity for healthy cropping systems
Proposed activities should:
•Develop and test site-specific innovations including management practices, solutions and tools that promote soil biodiversity, enhance soil health, stimulate plant growth, reduce chemical inputs to control soil borne plant diseases and root-feeding insects, and support ground nesting pollinators.
•Set up demonstration sites to test the proposed innovations and promote the benefits of soil biodiversity and healthy soils not only for growers and the agroecosystem but for the entire food value chain.
•Assess the social, economic and environmental issues associated with the proposed innovative solution, including trade-offs, the impact on labour, safety culture, and risk management on farms.
•Generate comprehensive capacity building material, organize trainings or knowledge sharing activities, including the development of guidelines to accelerate the dissemination, uptake and upscale of results.
•Enhance peer-to-peer learning with relevant stakeholders from farmers and advisors to policy makers and consumers, supporting a coordinated scientific and policy approach towards healthy soils.
Budget: 8.000.000 EUR, indicative number of grants: 2
Deadline: 08 October 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Widening participation and strengthening the European Research Area Call Identifier: HORIZON-WIDERA-2024-TALENTS-03-01 ERA Talents
ERA Talents scheme promotes inter-sectoral collaboration in R&I through cross-sectoral exchange of staff with a focus on Widening countries. ERA Talents seeks to support the training and mobility of researchers, innovators, and/or other R&I talents across sectors, focusing on Widening countries.
The proposals should address one or both of following aspects related to improving training and lifelong learning opportunities for researchers, innovators, and other research and innovation talents. In particular:
•training in skills and competences following specific demand from other sectors (notably the business sector), leading to improved employability of individuals, increased access to knowledge for the host organisation, and overall strengthened interoperability of careers between the sectors involved; skills can particularly include entrepreneurship, use of digital tools, knowledge valorisation, intellectual property rights, and the greening of society.
•training to build R&I support capacity in both the academic and non-academic sectors, such as administrative, managerial, and technical staff supporting R&I activities and capacities in their organisations (e.g., data stewards, research managers and administrators, research infrastructure operators, knowledge valorisation officers).
Budget: 1.000.000 to 3.000.000 EUR, indicative number of grants: 20
Deadline: 26 September 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes
MSCA
Doctoral Network
Call Identifier: HORIZON-MSCA-2024-DN-01-01
MSCA Doctoral Networks 2023 (HORIZON-MSCA-2024-DN-01-01)
MSCA Doctoral Networks will implement doctoral programmes, by partnerships of universities, research institutions and research infrastructures, businesses including SMEs, and other socio-economic actors from different countries across Europe and beyond.
Proposals for doctoral networks can reflect existing or planned research partnerships among the participating organisations.
The selection procedure for doctoral candidates must be open, transparent and merit-based, in line with the Code of Conduct for the Recruitment of Researchers.
MSCA Doctoral Networks are encouraged to lead to Industrial or Joint Doctorates.
Industrial Doctorates: Through Industrial Doctorates, doctoral candidates will step outside academia and develop skills in industry and business by being jointly supervised by academic and non-academic organisations, both of which can be established in the same EU Member State or Horizon Europe Associated Country.
Joint Doctorates: Joint Doctorates represent a highly integrated type of international, inter-sectoral and multi/interdisciplinary collaboration in doctoral training. They lead to the delivery of joint, double or multiple doctoral degrees recognised in at least two EU Member States or Horizon Europe Associated Countries.
Budget: EUR 608.000.000 (MSCA-DN) (single stage), 540 PM (in 2022 360 PM)
Deadline: 27 November 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in the MSCA part of the Work Programme.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
MSCA Doctoral Networks will implement doctoral programmes, by partnerships of universities, research institutions and research infrastructures, businesses including SMEs, and other socio-economic actors from different countries across Europe and beyond.
Proposals for doctoral networks can reflect existing or planned research partnerships among the participating organisations.
The selection procedure for doctoral candidates must be open, transparent and merit-based, in line with the Code of Conduct for the Recruitment of Researchers.
MSCA Doctoral Networks are encouraged to lead to Industrial or Joint Doctorates.
Industrial Doctorates: Through Industrial Doctorates, doctoral candidates will step outside academia and develop skills in industry and business by being jointly supervised by academic and non-academic organisations, both of which can be established in the same EU Member State or Horizon Europe Associated Country.
Joint Doctorates: Joint Doctorates represent a highly integrated type of international, inter-sectoral and multi/interdisciplinary collaboration in doctoral training. They lead to the delivery of joint, double or multiple doctoral degrees recognised in at least two EU Member States or Horizon Europe Associated Countries.
Budget: EUR 608.000.000 (MSCA-DN) (single stage), 540 PM (in 2022 360 PM)
Deadline: 27 November 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in the MSCA part of the Work Programme.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Call Identifier: HORIZON-MSCA-2024-SE-01-01 MSCA Staff Exchanges 2024 (HORIZON-MSCA-2024-SE-01-01)
MSCA Staff Exchanges involve organisations from the academic and non-academic sectors (including SMEs) from across the globe.
•Support is provided for international, inter-sectoral and interdisciplinary mobility of R&I staff leading to knowledge transfer between participating organisations.
•The organisations constituting the partnership contribute directly to the implementation of a joint R&I project by seconding and/or hosting eligible staff members.
•Such a project must explore activities that can be based on previous work but should go beyond and generate or strengthen long-term collaborations. Secondments must involve physical mobility of the eligible staff members and must always take place between legal entities independent from each other.
MSCA Staff Exchanges can address three dimensions of mobility: international, inter-sectoral and interdisciplinary.
Budget: EUR 81.226.000 (for year 2024)
Deadline: 05 March 2025 (Opening date: 10 October 2024)
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in the MSCA part of the Work Programme.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Call Identifier: HORIZON-MSCA-2024-COFUND-01-01 MSCA COFUND 2024 (HORIZON-MSCA-2024-COFUND-01)
Applicants submit proposals for new or existing doctoral or postdoctoral programmes with an impact on the enhancement of human resources in R&I at regional, national or international level.
•Proposed programmes can cover any research disciplines ("bottom-up"), but exceptionally can also focus on specific disciplines, notably when they are based on national or regional Research and Innovation Strategies for Smart Specialisation (RIS3 strategies). In this case, the range of covered disciplines should allow reasonable flexibility for the researchers to define their topic.
•A Career Development Plan must be jointly established by the supervisor and each recruited researcher upon recruitment. In addition to research objectives, this Plan comprises the researcher's training and career needs, including training on transferable skills, teaching, planning for publications and participation in conferences and events aimed at opening science and research to citizens. The Plan must be established at the beginning of the recruitment and should be revised (and updated where needed) within 18 months.
Budget: EUR 104.800.000 (for year 2024)
Deadline: 26 September 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in the MSCA part of the Work Programme.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Call Identifier: HORIZON-MSCA-2024-PF-01-01 MSCA Postdoctoral Fellowships 2024
The goal of MSCA Postdoctoral Fellowships is to enhance the creative and innovative potential of researchers holding a PhD and who wish to acquire new skills through advanced training, international, inter-sectoral and interdisciplinary mobility.
Postdoctoral Fellowships either can take place in Europe (i.e. in an EU Member State or a Horizon Europe Associated Country) or in a Third Country not associated to Horizon Europe:
•European Postdoctoral Fellowships are open to researchers of any nationality who wish to engage in R&I projects by either coming to Europe from any country in the world or moving within Europe. The standard duration of these fellowships must be between 12 and 24 months.
•Global Postdoctoral Fellowships are open to European nationals or long-term residents who wish to engage in R&I projects with organisations outside EU Member States and Horizon Europe Associated Countries. These fellowships require an outgoing phase of minimum 12 and maximum 24 months in a non-associated Third Country, and a mandatory 12-month return.
Budget: 354.600.000 EUR (European Fellowships);
62.58.000 EUR (Global Fellowships)
Deadline: 11 September 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes
Widening participation and strengthening the European Research Area Call Identifier: HORIZON-WIDERA-2024-TALENTS-02-01 ERA Fellowships
Fellowships should be provided to excellent researchers, undertaking cross-border mobility. Applications must be made jointly by the researcher together with a legal entity in the academic or non-academic sector located in a Widening Country.
•In order to apply for the ERA Fellowships call, applicants must submit their proposal to the Marie Skłodowska-Curie actions (MSCA) Postdoctoral Fellowships 2024. To be eligible to this call the host organisation must be located in an eligible Widening country.
•The proposals submitted under the ERA Fellowships must fulfil all the admissibility and eligibility conditions of the MSCA Postdoctoral Fellowships 2024 and pass all the thresholds for that call.
•ERA Fellowships will be implemented applying the award criteria, scoring and threshold for Marie Skłodowska-Curie actions.
Budget: 8.000.000 EUR for year 2024
Deadline: 11 September 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes
Innovative Europe
European Innovation Council (EIC)
Call Identifier: HORIZON-EIC-2024-PATHFINDER CHALLENGES
EIC Pathfinder Challenges 2024
The EIC Pathfinder is a funding programme under Horizon Europe that offers support to research teams by:
•funding research to develop the scientific basis to underpin breakthrough technologies
•supporting the earliest stages of scientific, technological or deep-tech R&D
•aiming to build on new, cutting-edge directions in science and technology to disrupt a field and a market or create new opportunities
•realising innovative technological solutions to identify, develop and scale up breakthrough technologies and disruptive innovations in Europe
The specific objectives of this Challenge are:
•”Solar-to-X” devices Towards cement and concrete as a carbon sink.
•Nature inspired alternatives for food packaging and films.
•Nanoelectronics for energy-efficient smart edge devices.
•Protecting EU space infrastructure.
Budget: up to 4 EUR million; Total indicative budget topic: 120 EUR million
Deadline: 16 October 2024
Who can apply: Smaller consortia (at least two eligible entities) or and single applicants as well as larger consortia.
The EIC Pathfinder is a funding programme under Horizon Europe that offers support to research teams by:
•funding research to develop the scientific basis to underpin breakthrough technologies
•supporting the earliest stages of scientific, technological or deep-tech R&D
•aiming to build on new, cutting-edge directions in science and technology to disrupt a field and a market or create new opportunities
•realising innovative technological solutions to identify, develop and scale up breakthrough technologies and disruptive innovations in Europe
The specific objectives of this Challenge are:
•”Solar-to-X” devices Towards cement and concrete as a carbon sink.
•Nature inspired alternatives for food packaging and films.
•Nanoelectronics for energy-efficient smart edge devices.
•Protecting EU space infrastructure.
Budget: up to 4 EUR million; Total indicative budget topic: 120 EUR million
Deadline: 16 October 2024
Who can apply: Smaller consortia (at least two eligible entities) or and single applicants as well as larger consortia.
European Innovation Council (EIC) Call Identifier: HORIZON-EIC-2024-TRANSITION-01) EIC Transition Open 2024
The EIC Transition is a funding programme under Horizon Europe targeting innovation activities that goes beyond the experimental proof of principle in laboratory. It supports both the maturation and validation of novel technologies from the lab to the relevant application environments.
The EIC Transition offers support to SMEs, start-ups and organisations that:
•have identified EU-funded project result(s) with promising commercial potential that could be the basis for innovation and promising new businesses.
•envision novel promising technology that is ready for the next steps towards its maturation and validation, to be further developed and validated for some specific, high potential, commercial applications.
•have conducted a preliminary market research to identify potential markets for their innovation and explored potential competitors.
•envisage building a motivated and entrepreneurial team with a mix of skills, including researchers, business people, marketers etc. to develop and drive the idea towards commercial success.
Budget: Grants of up to EUR 2.5 million to validate and demonstrate technology in application-relevant environment (starting at TRL 3/ 4 aiming at achieving TRL 5/ 6) and develop business and market readiness.
Total indicative budget topic: 94 EUR million.
Deadline: 18 September 2024
Who can apply: Your proposal must build on results (at least experimental proof of concept TRL 3, ideally technology validated in the lab TRL 4) already achieved within an eligible project. You can apply for EIC Transition either as:
• A single legal entity established in a Member State or an Associated Country (‘mono-beneficiary’).
• A small consortium of two independent legal entities from two different Member States or Associated Countries or
• A consortium of minimum three and maximum five independent legal entities (‘multi-beneficiary’) following standard rules i.e. must include at least one legal entity established in a Member State and at least two other independent legal entities, each established in different Member States or Associated Countries.
• The legal entities may for example be a start-up, an SME or research performing organisation (university, research or technology organisation, including teams, individual Principal Investigators and inventors in such institutions who intend to form a spinout company).
• The standard admissibility and eligibility conditions as well as the eligibility of applicants from third countries are detailed in Annex 2 of the EIC Work Programme 2024.
European Innovation Council (EIC) Call Identifier: HORIZON-EIC-2024-ACCELERATOR-01) EIC Accelerator 2024
The EIC Accelerator is a funding programme under Horizon Europe that offers support to start-ups and SMEs that:
•have a innovative, game changing product, service or business model that could create new markets or disrupt existing ones in Europe and even worldwide.
•have the ambition and commitment to scale up.
•are looking for substantial funding, but the risks involved are too high for private investors alone to invest.
Budget: Grant component below EUR 2.5M for innovation activities (starting at TRL 5 or 6 aiming at achieving higher TRLs). Investment component of EUR 0.5 up to 15 million for scaling up and other activities.
Grant only and investment only component under ce
Deadline: 3 October 2024 (full application); any time (short application)
Who can apply: To be an eligible applicant to EIC Accelerator, you must apply as one of the following eligible entities:
• A single company classified as a SME, and established within a Member State or an Associated Country (see Annex 2 of the EIC Work Programme 2024); or
• A single company classified as a small mid-cap (up to 499 employees) established in a Member State or an Associated Country, but only for exceptional cases for rapid scale up purposes; or
• One or more natural persons (including individual entrepreneurs) or legal entities, which are either:
a. from a Member State or an Associated Country intending to establish an SME or small mid-cap (as defined above) in a Member State or Associated Country by the time of signing the EIC Accelerator grant agreement or, in case the equity only is awarded, at the latest at the date of signature of the agreement on its investment component;
b. intending to invest in an SME or small mid-cap established in a Member State or an Associated Country and may submit a proposal on behalf of that SME or small mid-cap, provided that a prior agreement exists with the company. The grant agreement and/or the investment agreement will be signed with the beneficiary/final recipient of funding company only; or
c. from a non-associated third country intending to establish an SME (including start-ups) or to relocate an existing SME to a Member State or an Associated Country. Your company must prove its effective establishment in a Member State or an Associated Country at the time of submission of the full proposal.
The standard admissibility and eligibility conditions are detailed in Annex 2 of the EIC Work Programme 2024.
European Innovation Council (EIC) Call Identifier: EIC Accelerator Challanges EIC Accelerator Challanges 2024
The EIC Accelerator is a funding programme under Horizon Europe that offers support to start-ups and SMEs that:
•have a innovative, game changing product, service or business model that could create new markets or disrupt existing ones in Europe and even worldwide.
•have the ambition and commitment to scale up.
•are looking for substantial funding, but the risks involved are too high for private investors alone to invest.
The specific objectives of this Challenge are:
•Human Centric Generative AI
•Virtual worlds and augmented interaction, including support to Industry 5.0
•Enabling the smart edge & quantum technology components
•Food from precision fermentation and algae
•Monoclonal antibody-based therapeutics for emerging viruses
•Renewable energy sources and their whole value chain
Budget: Grant component below EUR 2.5M for innovation activities (starting at TRL 5 or 6 aiming at achieving higher TRLs). Investment component of EUR 0.5 up to 15 million for scaling up and other activities.
Grant only and investment only component under ce
Deadline: 4 October 2024 (full application); any time (short application)
Who can apply: Single start-ups and SMEs (including spin-offs), individuals (intending to launch a start-up/ SME) and in exceptional cases small mid-caps (fewer than 499 employees).
Excellent Science
European Research Council (ERC)
Call Identifier: ERC-2024-POC
ERC Proof of Concept Grant
Have you already received an ERC grant for your frontier research project and now want to explore the commercial or societal potential of your work?
The ERC Proof of Concept Grant could be for you.
Budget: Lump sum of EUR 150. 000 for a period of 18 months.
The ERC expects that normally Proof of Concept activities should be completed within 12 months. However, to allow for those projects that require more preparation time, the grant agreements will be s
Deadline: 17 September 2024
Who can apply: All Principal Investigators in one of the main grants are eligible to participate and apply for an ERC Proof of Concept Grant. Principal Investigators in an ongoing main grant, or Principal Investigators in a main grant that has ended after 1 January 2023, are eligible to apply, subject to any restrictions provided in Annex 3 to this Work Programme.
Principal Investigators may submit only one proposal under the Work Programme 2024 Proof of Concept call. If further submissions are made at different cut-off dates, only the first admissible and eligible proposal will be considered.
All proposals must be complete, readable, accessible, and be submitted before the relevant deadline.
Please pay attention to the new feature: As of 2024, applications to the Proof of Concept Grant will be evaluated and selected in TWO instead of three rounds, based on two specific cut-off dates.
A maximum of three Proof of Concept Grants may be awarded per main grant project, except for Synergy Grant, in which case a maximum of six Proof of Concept Grants may be awarded per ERC funded project.
Proof of Concept Grants may run in parallel provided they comply with the eligibility conditions set out in the Work Programme under which they have been awarded.
Have you already received an ERC grant for your frontier research project and now want to explore the commercial or societal potential of your work?
The ERC Proof of Concept Grant could be for you.
Budget: Lump sum of EUR 150. 000 for a period of 18 months.
The ERC expects that normally Proof of Concept activities should be completed within 12 months. However, to allow for those projects that require more preparation time, the grant agreements will be s
Deadline: 17 September 2024
Who can apply: All Principal Investigators in one of the main grants are eligible to participate and apply for an ERC Proof of Concept Grant. Principal Investigators in an ongoing main grant, or Principal Investigators in a main grant that has ended after 1 January 2023, are eligible to apply, subject to any restrictions provided in Annex 3 to this Work Programme.
Principal Investigators may submit only one proposal under the Work Programme 2024 Proof of Concept call. If further submissions are made at different cut-off dates, only the first admissible and eligible proposal will be considered.
All proposals must be complete, readable, accessible, and be submitted before the relevant deadline.
Please pay attention to the new feature: As of 2024, applications to the Proof of Concept Grant will be evaluated and selected in TWO instead of three rounds, based on two specific cut-off dates.
A maximum of three Proof of Concept Grants may be awarded per main grant project, except for Synergy Grant, in which case a maximum of six Proof of Concept Grants may be awarded per ERC funded project.
Proof of Concept Grants may run in parallel provided they comply with the eligibility conditions set out in the Work Programme under which they have been awarded.
European Research Council (ERC) Call Identifier: ERC-2024-Adv ERC Advanced Grant
Are you an established, leading principal investigator who wants long-term funding to pursue a ground-breaking, high-risk project?
The ERC Advanced Grant could be for you.
Applicants for the ERC Advanced Grants - called Principal Investigators (PI) - are expected to be active researchers who have a track-record of significant research achievements in the last 10 years.
Budget: Up to EUR 2 500 000 for a period of 5 years. Additional funding up to EUR 1 000 000.
Deadline: 29 August 2024
Who can apply: Applicants for the ERC Advanced Grants - called Principal Investigators (PI) - are expected to be active researchers who have a track-record of significant research achievements.
The Principal Investigators should be exceptional leaders in terms of originality and significance of their research contributions. No specific eligibility criteria with respect to the academic requirements are foreseen.
EU4Health
Call Identifier: EU4H-2024-PJ-01-1
Call for proposals on the European Hub for vaccine development (HERA) - CP-g-24-10
•This action aims to create a European Hub for public health-relevant vaccine development, combining excellence in vaccine development with clinical trials and activities for scaling manufacturing.
•This call targets consortia of developers of vaccines covering expertise in development including publicly funded and industrial organisations.
•The Hub will develop a strategic vaccine plan for Europe, and subsequently deliver on creating vaccine prototypes in particular for priority pathogens with epidemic and pandemic potential, further developing of state-of-the-art technologies that can be rapidly adapted, preparing relevant master clinical trial protocols, combining its activities to reach out to clinical trial capacities/networks and at scale production initiatives at national and European levels.
•The Hub should establish connections with private manufacturers including through specific manufacturing agreements such as EUFAB or comparable national models.
Budget: Total: 102.000.000 EUR. Nr. of projects funded: 1.
Expected duration: 48 months.
Deadline: 05 September 2024
Who can apply: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 entities from 3 different eligible countries. Please consult the call text for specific requirements.
Funding rate: co-financing will be needed, since grants paid by the Union shall not exceed 60 % of eligible costs for an action unless in cases of exceptional utility, where the contribution by the Union may be up to 80 %.
Overhead costs is restricted to 7% of the eligible direct costs.
•This action aims to create a European Hub for public health-relevant vaccine development, combining excellence in vaccine development with clinical trials and activities for scaling manufacturing.
•This call targets consortia of developers of vaccines covering expertise in development including publicly funded and industrial organisations.
•The Hub will develop a strategic vaccine plan for Europe, and subsequently deliver on creating vaccine prototypes in particular for priority pathogens with epidemic and pandemic potential, further developing of state-of-the-art technologies that can be rapidly adapted, preparing relevant master clinical trial protocols, combining its activities to reach out to clinical trial capacities/networks and at scale production initiatives at national and European levels.
•The Hub should establish connections with private manufacturers including through specific manufacturing agreements such as EUFAB or comparable national models.
Budget: Total: 102.000.000 EUR. Nr. of projects funded: 1.
Expected duration: 48 months.
Deadline: 05 September 2024
Who can apply: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 entities from 3 different eligible countries. Please consult the call text for specific requirements.
Funding rate: co-financing will be needed, since grants paid by the Union shall not exceed 60 % of eligible costs for an action unless in cases of exceptional utility, where the contribution by the Union may be up to 80 %.
Overhead costs is restricted to 7% of the eligible direct costs.
Call Identifier: EU4H-2024-PJ-01-2 Call for proposals for next-generation respiratory protection (HERA) - CP-g-24-11
•Applicants might develop completely new technologies or rely on reformulated designs and novel applications of existing materials and technologies.
•Applicants need to propose a detailed plan to design, prototype, validate, and CE-mark innovative, cost-effective, and sustainable next-generation respirators.
•Proposals should include a dissemination and market readiness plan that ensures a market for the product in preparedness times – e.g., through stockpiling or active use.
•Developers also need to demonstrate feasibility for a rapid production scale-up once a public health emergency materialises, possibly relying on distributed manufacturing solutions and use of accessible raw materials.
Products should (i)demonstrate the potential to be at a cost that will allow for a switch from the currently used PPE and (ii) be reusable, less harmful to the environment and ideally foster environmentally friendly production.
Proposals need to take into consideration that next generation respiratory devices should be easy to store and simple to use by the target population.
Budget: Total: 20.000.000 EUR. Nr. of projects funded: 4 (indicative project budget 5.000.000 EUR).
Expected duration: 48 months.
Deadline: 05 September 2024
Who can apply: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 entities from 3 different eligible countries. Please consult the call text for specific requirements.
Funding rate: co-financing will be needed, since grants paid by the Union shall not exceed 60 % of eligible costs for an action unless in cases of exceptional utility, where the contribution by the Union may be up to 80 %.
Overhead costs is restricted to 7% of the eligible direct costs.
Call Identifier: EU4H-2024-PJ-01-3 Call for proposals to support innovative manufacturing technologies and processes in the Union for medicines production (HERA) - CP-g-24-12
This action covers activities aimed at developing support for or innovations targeting the manufacturing of APIs, their intermediates and/or excipients, namely by developing:
a) novel manufacturing processes and technologies, e.g., additive manufacturing, continuous manufacturing and flow chemistry, and biomanufacturing technologies; combined or not with activities covering: b) novel industrial manufacturing and facility designs, e.g., modular manufacturing, smart manufacturing execution systems, including automation and robotics, advanced analytics, and smart sensors, among other.
Overall, the action should contribute to increasingly sophisticated enhancements to chemical and/or biological processes or decreasing the production of polluting agents. This action is limited to manufacturing technologies and processes and does not cover innovation exclusively targeting the field of quality control.
Budget: Total: 17.000.000 EUR. Nr. of projects funded: 3 (indicative project budget 5.600.000 EUR).
Expected duration: 24 to 48 months.
Deadline: 05 September 2024
Who can apply: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 entities from 3 different eligible countries. Please consult the call text for specific requirements.
Funding rate: co-financing will be needed, since grants paid by the Union shall not exceed 60 % of eligible costs for an action unless in cases of exceptional utility, where the contribution by the Union may be up to 80 %.
Overhead costs is restricted to 7% of the eligible direct costs.
Call Identifier: EU4H-2024-PJ-01-4 Call for proposals to support the development of novel antivirals (HERA) - CP-g-24-105
This action aims to:
•support the development and further characterisation of broad-spectrum antivirals (BSA) targeting identified HERA priority viral families, which largely can be divided among respiratory RNA viral families, such as Paramyxo-, Orthomyxo and Coronaviridae, as well as those targeting viral families known for causing viral haemorrhagic fever (VHF), such as Arena-, Bunya-, Flavi-, Filoviridae.
•identify a potent BSA candidate, in order to advance its clinical development.
•cover early safety and efficacy trials for testing new or improved anti-viral therapeutics, with a clear regulatory and clinical pathway, including first in humans.
• support innovative delivery systems and suitable safety profiles for broad use should be considered when possible as well as the application of novel approaches and widely applicable workflows (e.g. artificial intelligence) for rapid and reliable identification of broad-spectrum anti-viral therapeutics.
Budget: Total: 10.000.000 EUR. Nr. of projects funded: 1.
Expected project duration: 24 months.
Deadline: 05 September 2024
Who can apply: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 entities from 3 different eligible countries. Please consult the call text for specific requirements.
Funding rate: co-financing will be needed, since grants paid by the Union shall not exceed 60 % of eligible costs for an action unless in cases of exceptional utility, where the contribution by the Union may be up to 80 %.
Overhead costs is restricted to 7% of the eligible direct costs.
Call Identifier: EU4H-2024-PJ-02-1 Call for Proposal to support integration of cancer images into the federated pan-European infrastructure to foster screening programmes - CR-g-24-37
Scope: This action contributes to the implementation of the Europe’s Beating Cancer Plan.
The action will:
•provide enabling support for cancer imaging data providers, to contribute to and benefit from the European Cancer Imaging Initiative.
•improve readiness of national, regional or local imaging data repositories to connect and make available their data via the Cancer Image Europe infrastructure established under the DIGITAL programme (EUCAIM project) and to use this infrastructure for data enrichment and insights by accessing the nodes, tools and methodologies offered by EUCAIM.
•explore ways to leverage on the EHDS interoperability specifications for the European Electronic Health Record exchange Format, including relevant eHealth Network guidelines, as well as minimum specifications for datasets to be used for research and innovation.
•support the Europe’s Beating Cancer Plan objective to ensure high standards in cancer care and implements the EU4Health Programme’s general objective of improving and fostering health in the Union to reduce the burden of communicable and non-communicable diseases.
•support the implementation of the proposed EHDS Regulation and implement the EU4Health Programme’s general objective of strengthening health systems.
Budget: Total: 8.000.000 EUR. Nr. of projects funded: 2 (indicative project budget 4.000.000 EUR).
Expected project duration: 36 to 48 months
Deadline: 10 October 2024
Who can apply: A consortium composed of at least 7 applicant organisations established in at least 7 different eligible countries.
Academia and education establishments, research institutes, hospitals, expert networks including ERNs, civil cociety organisations: associations, foundations, NGOs and similar entities, private entities (for profit/not for profit), Member States’ authorities.
The costs will be reimbursed at the funding rate fixed in the Grant Agreement (60%). You can apply for a higher project funding rate (80%) if your project is of ‘exceptional utility’.
Overhead costs is restricted to 7% of the eligible direct costs, except volunteers costs and exempted specific cost categories, if any.
Call Identifier: EU4H-2024-PJ-02-2 Call for Proposals to increase health literacy for cancer prevention and care - CR-g-24-39
Scope: This action contributes to the implementation of the Europe’s Beating Cancer Plan.
The action should aim to improve health literacy:
•of citizens, of patients of all ages, as well as of healthcare professionals.
•of citizens on cancer prevention and provide them access to adequate and reliable health information.
•of patients by providing adequate, reliable, and timely information on their diagnosis and treatment to achieve their disease understanding and active involvement in the treatment.
•in palliative care.
•education of health professionals.
Provide access to reliable, accurate and easy-to understand information to:
•improve access to reliable, accurate cancer information in different languages, with attention to varying digital and literacy skills and accessibility.
•improve access to reliable, accurate information on the internet, to combat misinformation available online / in social media to educate and protect citizens and patients from misinformation on the Internet and social media.
•support cancer literacy in relation to emotional impact and psychosocial distress of cancer patients.
Promote health literacy, exchange of information and best practices to:
•introduce a cancer health literacy day to raise awareness and promote its importance.
•support the generation and dissemination of evidence and good practices, including at population level.
•gather lessons learned to enhance health literacy in general, for example, through the establishment of cancer literacy projects.
•get an overview of health literacy programmes developed within healthcare systems and in the community.
•reflect on the role of health literacy in cancer prevention and care, potential gaps, and recommendations for action.
Budget: Total: 5.000.000 EUR. Nr. of projects funded: 5 (indicative project budget 1.000.000 EUR).
Expected project duration: 36 months
Deadline: 10 October 2024
Who can apply: Applications may be either by a single applicant or a consortium (no minimum requirement).
Academia and education establishments, research institutes, hospitals, expert networks, civil society organisations: associations, foundations, NGOs, enterprises (incl. social enterprises and not for profit) in the field of public health, private entities, social media outlets press and journalist association, Member States’ authorities.
The costs will be reimbursed at the funding rate fixed in the Grant Agreement (60%). You can apply for a higher project funding rate (80%) if your project is of ‘exceptional utility’.
Overhead costs is restricted to 7% of the eligible direct costs, except volunteers costs and exempted specific cost categories, if any.
Call Identifier: EU4H-2024-PJ-02-3 Call for proposals on the development of social services for psychosocial support and rehabilitation for children and their families in paediatric oncology clinics in Member States and countries associated to the EU4Health Programme - CR-g-24-43
The scope of this action is to address the critical need for comprehensive psychosocial care in paediatric oncology clinics across Member States and countries associated with the EU4Health Programme.
The action aims to support the establishment of a unified service system and support infrastructure to deliver psychological and social support to children, adolescents, and young adults undergoing cancer treatment, as well as their families. This includes developing organizational structures, training programs, and tools tailored to the unique needs of paediatric oncology patients.
Additionally, the action will conduct a thorough assessment of existing psychosocial services across Europe to identify best practices, gaps and opportunities for improvement.
Through collaboration and knowledge sharing, the action seeks to enhance the quality of life and well-being of paediatric cancer patients and their families, ultimately contributing to the broader goals of Europe’s Beating Cancer Plan and the EU4Health Programme.
Budget: Total: 7.400.000 EUR. Nr. of projects funded: 2 (indicative project budget 3.700.000 EUR).
Expected project duration: 36 months
Deadline: 10 October 2024
Who can apply: A consortium composed of at least 10 applicant organisations established in at least 5 different eligible countries.
Academia and education establishments, research institutes, hospitals, expert networks, civil society organisations, associations, foundations, NGOs, private entities (for profit/not for profit); international organisations, Member States’ authorities, municipalities and national authorities in the health domain.
The costs will be reimbursed at the funding rate fixed in the Grant Agreement (60%). You can apply for a higher project funding rate (80%) if your project is of ‘exceptional utility’.
Overhead costs is restricted to 7% of the eligible direct costs, except volunteers costs and exempted specific cost categories, if any.
Call Identifier: EU4H-2024-PJ-02-4 Call for Proposals on EU Network of Youth Cancer Survivors - CR-g-24-45
The overall aim of maintaining the networks is to continue the collaboration between different existing stakeholder organisations and, through this network to further support social networking and further develop user friendly digital tools to easily access the information and improve the links amongst individuals, patients, children, adolescents and young adults (CAYA) cancer survivors, carers, researchers, and social and health professionals active in cancer prevention and care across the Union and countries associated to the EU4Health Programme.
In addition, a healthy lifestyle promoting network could also be integrated in the mobile application and website. Furthermore, the network will consider relapse / metastatic cancer. The network should support and provide all the necessary information related to metastatic cancer.
The network will foster social networking, peer-support, coaching, knowledge-exchange, and aims at improving:
a) the quality of life of survivors (including mental health, education and career support, follow-up care and transition).
b) the care for adolescents and young adults (AYA) with cancer (including metastatic cancer).
c) Equality, Diversity and Inclusion (EDI) along the whole treatment and survivorship trajectory.
d) promote healthy lifestyles through interaction and exchange with peers, with people with a similar disease history, with friends as well as with healthcare organisations.
Budget: Total: 5.000.000 EUR. Nr. of projects funded: 1 (indicative project budget 5.000.000 EUR).
Expected project duration: 36 months
Deadline: 10 October 2024
Who can apply: A consortium composed of at least 5 applicant organisations established in at least 5 different eligible countries.
Academia and education establishments, research institutes, hospitals, expert networks, civil society organisations, associations, foundations, NGOs and similar entities. The costs will be reimbursed at the funding rate fixed in the Grant Agreement (60%). You can apply for a higher project funding rate (80%) if your project is of ‘exceptional utility’.
Overhead costs is restricted to 7% of the eligible direct costs, except volunteers costs and exempted specific cost categories, if any.
Circular Bio-based Europe Joint Undertaking
Call Identifier: HORIZON-JU-CBE-2024-IA-01
Bio-based materials and products for biodegradable in-soil applications
Proposals under this topic should:
•Demonstrate and deploy innovative production processes for sustainable bio-based products for biodegradable -in- soil applications, addressing the problem of (micro)plastics release in soil and their further dispersion in runoff water.
•The topic does not cover marine and aquatic applications as a main focus. However, spill over of the developed product streams towards other replication sectors (including marine/aquatic) can be considered, in order to widen market applications.
•Design the products for biodegradation in soil according to the environmental conditions and application timeframe, while ensuring technical performances meeting market requirements throughout the useful life of the product.
•Demonstrate safe biodegradability of bio-based products designed for specific applications in open environments (soil) under ranges of physical/chemical environmental conditions, including extreme conditions (e.g., temperature, pH) where applicable.
•Develop a proposal for appropriate labelling of products when applicable and provide clear instructions on their use and on disposal options after use. This task should include the consultation of targeted stakeholders, e.g., end users. Training of end users should also be envisaged.
•Contribute with recommendations related to standards for biodegradability in soil.
Budget: 7.500.000 EUR, indicative number of grants: 2
Deadline: 18 September 2024
Who can apply: See details in the call text.
Proposals under this topic should:
•Demonstrate and deploy innovative production processes for sustainable bio-based products for biodegradable -in- soil applications, addressing the problem of (micro)plastics release in soil and their further dispersion in runoff water.
•The topic does not cover marine and aquatic applications as a main focus. However, spill over of the developed product streams towards other replication sectors (including marine/aquatic) can be considered, in order to widen market applications.
•Design the products for biodegradation in soil according to the environmental conditions and application timeframe, while ensuring technical performances meeting market requirements throughout the useful life of the product.
•Demonstrate safe biodegradability of bio-based products designed for specific applications in open environments (soil) under ranges of physical/chemical environmental conditions, including extreme conditions (e.g., temperature, pH) where applicable.
•Develop a proposal for appropriate labelling of products when applicable and provide clear instructions on their use and on disposal options after use. This task should include the consultation of targeted stakeholders, e.g., end users. Training of end users should also be envisaged.
•Contribute with recommendations related to standards for biodegradability in soil.
Budget: 7.500.000 EUR, indicative number of grants: 2
Deadline: 18 September 2024
Who can apply: See details in the call text.
Call Identifier: HORIZON-JU-CBE-2024-RIA-05 Innovative bio-based food/feed ingredients
Proposals under this topic should:
•Develop innovative food and/or feed ingredients from sustainably sourced bio-based feedstock. The innovation in scope can be related to i) breakthrough processes to obtain known food/feed ingredients, and/or ii) novel food/feed ingredients.
• Ingredients in scope include bioactive compounds, antioxidants, prebiotics, postbiotics, vitamins, peptides, oligosaccharides; fats; emulsifiers; taste, texture, palatability and digestibility enhancers; colourants, functional/’precision proteins’ (i.e. proteins obtained, for example but not only, from precision fermentation process) among others.
•Any production technique is in scope; proposals are required to pay particular attention to environmental, social and economic sustainability of the chosen pathway (including ingredients’ sources and availability/supply and the use of natural resources such as land, water, energy). In addition to production processes, proposals should consider downstream separation and purification processes to meet the targeted quality for final application aligned with food and safety legal requirements.
•Test the properties of the functional ingredients developed, alone and/or in combination and, if applicable, their effect on product formulations according to established testing procedures. Moreover, proposals should test the safety of developed ingredients through in vitro toxicological tests.
•Address the regulatory aspects relevant to the targeted end market(s), ensuring compatibility in the perspective of potential future scale-up.
•Involve end users starting from the early stages of development to assess market acceptance of the new ingredients. When addressing consumer products, involve consumers to gain insight of their perception and future chances of market uptake.
Budget: 3.500.000 EUR, indicative number of grants: 2
Deadline: 19 September 2024
Who can apply: See details in the call text.
Other Calls
Prima
Thematic Area 2 Farming systems in Nexus Call Identifier: TOPIC: 1.2.1-2024 (IA) Transformative adaptation of Mediterranean dry farming systems using water harvesting technique to address extreme drought in arid and semi-arid environments.
This call for proposals aims to address the challenges of dry-farming in arid Mediterranean areas by integrating traditional and modern hydro-technologies to create sustainable and resilient agricultural systems.
The focus is on systems that prioritize the use of saline-resistant and drought-resistant species or underutilized species with minimal water requirements, adapted to seasonal rainfall variations, and tolerant to solar radiation and elevated temperatures, including halophytes, cacti, and similar plants.
A circular economy approach is encouraged, promoting the recycling and re-use of various waste types as soil amendments, bio-fertilizers, or replacements for chemical inputs.
Proposals should prioritize evaluating the impact on soil health and the circular economy of water resources, alongside broader environmental assessments.
This approach enhances soil organic matter, carbon sequestration, water storage, nutrient use efficiency, and efficient water usage while considering the specific needs and contributions of women and men in the community.
Budget: total indicative budget: 9.6 million EUR
Deadline: Stage 1 Pre-proposals – 02 April, 2024
Stage 2 Full proposals – 25 September, 2024
Who can apply: See details in the call text.
Thematic Area 3 Food value chain in the Nexus Call Identifier: TOPIC: 1.3.1 (IA) Developing cost-effective and sustainable technologies adapted to Mediterranean Food Systems to decrease food loss and waste.
This call aims to support the deployment and demonstration of sustainable solutions to reduce food losses and waste, save energy, and enhance food safety during postharvest activities, including transportation, storage, and processing. The specific focus is on plant-based food and waste.
These solutions should be scalable, sustainable, cost-effective, and tailored to smallholders in rural areas with limited access to electricity.
Proposals should implement processes and technologies adapted to Mediterranean food systems and climate conditions, ensuring a decrease in food losses and waste, prolonging food shelf-life, and enhancing food safety in different regions of the Mediterranean.
The emphasis should be on the exploitation and dissemination of results, meaning that projects should not only focus on research and development but also on effectively utilizing and commercializing the outcomes and findings.
Budget: total indicative budget: 9.1 million EUR
Deadline: Stage 1 Pre-proposals – 02 April, 2024
Stage 2 Full proposals – 25 September, 2024
Who can apply: See details in the call text.
Thematic Area 1-Water management in the Nexus Call Identifier: Topic 2.1.1-2024 (RIA) Effective water accounting approaches under crisis conditions: climate change and external shocks
This call aims to promote innovative water accounting approaches that can enhance the gathering, analysis and communication of information related to water flows, fluxes, stocks, and consumption in selected watersheds/basins, with a view to improving the management of water resources, even in the face of changing climate as well as geopolitical and socio-economic shocks.
Budget: total indicative budget to calls under Topic 2 : 34.7 million EUR
Deadline: Stage 1 Pre-proposals – 04 April, 2024
Stage 2 Full proposals – 26 September 2024
Who can apply: See details in the call text.
Thematic Area 2-Farming systems in the Nexus Call Identifier: Topic 2.2.1 (RIA) Revitalizing agroforestry practices for sustainable land use and climate resilience in the Mediterranean Region.
This call for proposals aims to support the revitalization of agroforestry systems, including silvo-arable and silvo-pastoral agroforestry, in the Mediterranean region.
The objective is to identify innovative strategies and overcome barriers to the adoption and scaling up of agroforestry practices.
Budget: total indicative budget to calls under Topic 2 (Multi-Topics): 34.7 million EUR
Deadline: Stage 1 Pre-proposals – 04 April, 2024
Stage 2 Full proposals – 26 September 2024 )
Who can apply: See details in the call text.
Thematic Area 3-Food value chain in the Nexus Call Identifier: Topic 2.3.1 (RIA) Leveraging urban and local food systems for sustainable food systems transformation.
Proposals should aim to strengthen regulatory frameworks for urban and peri-urban agriculture, paying particular attention to the unique challenges faced in the Southern Mediterranean countries.
This includes addressing issues related to land use planning, zoning regulations, and the socio-economic aspects of land access.
Policies should not only consider but actively incorporate gender-sensitive approaches to issues such as food safety, product labelling, and certification requirements.
Budget: total indicative budget to calls under Topic 2 (Multi-Topics): 34.7 million EUR
Deadline: Stage 1 Pre-proposals – 04 April, 2024
Stage 2 Full proposals – 26 September 2024)
Who can apply: See details in the call text.
Thematic Area 1
Water management in Nexus
Call Identifier: TOPIC: 1.1.1-2024 (IA)
Sustainability of Mediterranean irrigated agriculture through the implementation of WEFE Nexus approach
This call is designed to promote the creation of innovative solutions rooted in the Nexus approach, with a cross-sectoral perspective that enhances the sustainability of irrigated regions within the Mediterranean area.
Moreover, projects should focus on mitigating current challenges that obstruct the effective implementation of the WEFE Nexus approach when adopting novel irrigation technologies.
These challenges may include gaps in data availability, systemic disconnect between institutions, and uneven power distributions across sectors.
Through a multi-actor approach, the proposals should be demonstrated at large sites in irrigated areas that are experiencing recurrent or permanent water scarcity conditions and anticipate solutions for current and future challenges.
Proposals will support strategies for advancing the WEFE Nexus approach in practice, linking food systems with farming, ecosystem services and healthy diets.
Budget: total indicative budget: 9.2 million EUR
Deadline: Stage 1 Pre-proposals – 02 April, 2024
Stage 2 Full proposals – 25 September, 2024 (CET)
Who can apply: See details in the call text.
This call is designed to promote the creation of innovative solutions rooted in the Nexus approach, with a cross-sectoral perspective that enhances the sustainability of irrigated regions within the Mediterranean area.
Moreover, projects should focus on mitigating current challenges that obstruct the effective implementation of the WEFE Nexus approach when adopting novel irrigation technologies.
These challenges may include gaps in data availability, systemic disconnect between institutions, and uneven power distributions across sectors.
Through a multi-actor approach, the proposals should be demonstrated at large sites in irrigated areas that are experiencing recurrent or permanent water scarcity conditions and anticipate solutions for current and future challenges.
Proposals will support strategies for advancing the WEFE Nexus approach in practice, linking food systems with farming, ecosystem services and healthy diets.
Budget: total indicative budget: 9.2 million EUR
Deadline: Stage 1 Pre-proposals – 02 April, 2024
Stage 2 Full proposals – 25 September, 2024 (CET)
Who can apply: See details in the call text.
Thematic Area 2 Farming systems in Nexus Call Identifier: TOPIC: 1.2.1-2024 (IA) Transformative adaptation of Mediterranean dry farming systems using water harvesting technique to address extreme drought in arid and semi-arid environments.
This call for proposals aims to address the challenges of dry-farming in arid Mediterranean areas by integrating traditional and modern hydro-technologies to create sustainable and resilient agricultural systems.
The focus is on systems that prioritize the use of saline-resistant and drought-resistant species or underutilized species with minimal water requirements, adapted to seasonal rainfall variations, and tolerant to solar radiation and elevated temperatures, including halophytes, cacti, and similar plants.
A circular economy approach is encouraged, promoting the recycling and re-use of various waste types as soil amendments, bio-fertilizers, or replacements for chemical inputs.
Proposals should prioritize evaluating the impact on soil health and the circular economy of water resources, alongside broader environmental assessments.
This approach enhances soil organic matter, carbon sequestration, water storage, nutrient use efficiency, and efficient water usage while considering the specific needs and contributions of women and men in the community.
Budget: total indicative budget: 9.6 million EUR
Deadline: Stage 1 Pre-proposals – 02 April, 2024
Stage 2 Full proposals – 25 September, 2024
Who can apply: See details in the call text.
Thematic Area 3 Food value chain in the Nexus Call Identifier: TOPIC: 1.3.1 (IA) Developing cost-effective and sustainable technologies adapted to Mediterranean Food Systems to decrease food loss and waste.
This call aims to support the deployment and demonstration of sustainable solutions to reduce food losses and waste, save energy, and enhance food safety during postharvest activities, including transportation, storage, and processing. The specific focus is on plant-based food and waste.
These solutions should be scalable, sustainable, cost-effective, and tailored to smallholders in rural areas with limited access to electricity.
Proposals should implement processes and technologies adapted to Mediterranean food systems and climate conditions, ensuring a decrease in food losses and waste, prolonging food shelf-life, and enhancing food safety in different regions of the Mediterranean.
The emphasis should be on the exploitation and dissemination of results, meaning that projects should not only focus on research and development but also on effectively utilizing and commercializing the outcomes and findings.
Budget: total indicative budget: 9.1 million EUR
Deadline: Stage 1 Pre-proposals – 02 April, 2024
Stage 2 Full proposals – 25 September, 2024
Who can apply: See details in the call text.
Thematic Area 1-Water management in the Nexus Call Identifier: Topic 2.1.1-2024 (RIA) Effective water accounting approaches under crisis conditions: climate change and external shocks
This call aims to promote innovative water accounting approaches that can enhance the gathering, analysis and communication of information related to water flows, fluxes, stocks, and consumption in selected watersheds/basins, with a view to improving the management of water resources, even in the face of changing climate as well as geopolitical and socio-economic shocks.
Budget: total indicative budget to calls under Topic 2 : 34.7 million EUR
Deadline: Stage 1 Pre-proposals – 04 April, 2024
Stage 2 Full proposals – 26 September 2024
Who can apply: See details in the call text.
Thematic Area 2-Farming systems in the Nexus Call Identifier: Topic 2.2.1 (RIA) Revitalizing agroforestry practices for sustainable land use and climate resilience in the Mediterranean Region.
This call for proposals aims to support the revitalization of agroforestry systems, including silvo-arable and silvo-pastoral agroforestry, in the Mediterranean region.
The objective is to identify innovative strategies and overcome barriers to the adoption and scaling up of agroforestry practices.
Budget: total indicative budget to calls under Topic 2 (Multi-Topics): 34.7 million EUR
Deadline: Stage 1 Pre-proposals – 04 April, 2024
Stage 2 Full proposals – 26 September 2024 )
Who can apply: See details in the call text.
Thematic Area 3-Food value chain in the Nexus Call Identifier: Topic 2.3.1 (RIA) Leveraging urban and local food systems for sustainable food systems transformation.
Proposals should aim to strengthen regulatory frameworks for urban and peri-urban agriculture, paying particular attention to the unique challenges faced in the Southern Mediterranean countries.
This includes addressing issues related to land use planning, zoning regulations, and the socio-economic aspects of land access.
Policies should not only consider but actively incorporate gender-sensitive approaches to issues such as food safety, product labelling, and certification requirements.
Budget: total indicative budget to calls under Topic 2 (Multi-Topics): 34.7 million EUR
Deadline: Stage 1 Pre-proposals – 04 April, 2024
Stage 2 Full proposals – 26 September 2024)
Who can apply: See details in the call text.
National Calls
Italia domani - PNRR
Bandi e avvisi dei soggetti attuatori
Call Identifier: https://www.italiadomani.gov.it/content/sogei-ng/it/it/opportunita/bandi-soggetti-attuatori.html
Bandi e avvisi dei soggetti attuatori
In questa sezione è possibile consultare bandi e avvisi pubblici per cogliere le opportunità del PNRR volte a migliorare la vita pubblica di tutto il Paese.
Budget: Consultare il sito del bando
Deadline: Consultare il sito del bando
Who can apply: Consultare il sito del bando.
In questa sezione è possibile consultare bandi e avvisi pubblici per cogliere le opportunità del PNRR volte a migliorare la vita pubblica di tutto il Paese.
Budget: Consultare il sito del bando
Deadline: Consultare il sito del bando
Who can apply: Consultare il sito del bando.
Finanziamento IKIGAI - FMPS
Finanziamento di progetti individuali
Call Identifier: https://ikigai.fondazionemps.it/il-bando/
BANDO IKIGAI 2022 – 2024
Budget: Il bando sarà gestito con la collaborazione tecnica di Pluriversum Srl, società identificata dalla Fondazione come partner del progetto in virtù della consolidata conoscenza regionale di promozione e sostegno all’occupazione della società.
Per le modalità di erogazione e di partecipazione alle misure si rimanda agli specifici bandi e call che saranno pubblicati sui canali di comunicazione di IKIGAI (sul sito ikigaihub.it e sulle pagine social di IKIGAI), sui canali di comunicazione di Fondazione MPS (fondazionemps.it e ikigai.fondazionemps.it) e sulle comunicazioni a stampa.
Deadline: Consultare il sito del bando
Who can apply: Consultare il sito del bando.
Budget: Il bando sarà gestito con la collaborazione tecnica di Pluriversum Srl, società identificata dalla Fondazione come partner del progetto in virtù della consolidata conoscenza regionale di promozione e sostegno all’occupazione della società.
Per le modalità di erogazione e di partecipazione alle misure si rimanda agli specifici bandi e call che saranno pubblicati sui canali di comunicazione di IKIGAI (sul sito ikigaihub.it e sulle pagine social di IKIGAI), sui canali di comunicazione di Fondazione MPS (fondazionemps.it e ikigai.fondazionemps.it) e sulle comunicazioni a stampa.
Deadline: Consultare il sito del bando
Who can apply: Consultare il sito del bando.